Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
RougeTx is a biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction.
Nuclidium is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.
Tacalyx is a biotech company that develops therapies that target cancer by focusing on tumor-associated carbohydrate antigens.
Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
Charles helps men regain control over their daily health concerns by starting with their personal health.
Step Pharma is a biotechnology company.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
We are a virtual sleep clinic, using our own 3-gram sensor to diagnose sleep with gold standard quality.
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.
Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs.
Elkedonia is a biotech company dedicated to transforming antidepressant therapy.
Nuevocor operates as a preclinical-stage biotech company.
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
We digitize music therapy into engaging products for accessible technologies.
Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.
Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Optimized resource planning solution for healthcare institutions
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
Meiogenix is a biotechnology company that develops breeding technologies.
Radiology augmented GPT to tackle the complexity of precision medicine
Kurma Partners has invested in 85 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Kurma Partners's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, Alveus Therapeutics received $197.0M in a Series A round. Kurma Partners's total known invested capital is $2.6B.
Kurma Partners's average investment size is $30.5M across its portfolio of 85 companies.
Recent Kurma Partners portfolio additions include RougeTx, Nuclidium, Tacalyx, Laigo Bio, Charles.co. These companies were founded in 2020 or later.